Ping An Biomedical Co., Ltd. (PASW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Oct 1Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30

Key dataOct 30, 2026

Open$5.53

From 52W high−83.00%

Volume62332.00

Market cap$16.01M

P/E (TTM)—

P/S (TTM)4.2x

Div yield—

Key dataOct 30, 2026

Open

$5.53

From 52W high

−83.00%

Volume

62332.00

Market cap

$16.01M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−10.4x

P/E (TTM)

—

RSI (14)

44.1

MomentumView details →

1D Return

+2.40%

YTD Return

−78.49%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−10.4x

EV/Sales

4.3x

P/S (TTM)

4.2x

P/B (TTM)

1.4x

ProfitabilityView details →

Gross Margin

9.27%

Net Margin

−14.78%

EBITDA Margin

−41.32%

ROE (TTM)

−4.82%

ROA (TTM)

−3.76%

Asset Turnover

0.25x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

−33.20%

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

+2.40%

YTD Return

−78.49%

1Y Return

−85.62%

RSI (14)

44.1

vs 50D SMA

−15.90%

vs 200D SMA

−29.36%

Capital & dividendView details →

Debt/Equity

0.13x

Current Ratio

2.54x

Quick Ratio

2.54x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

25.51M

Net Income (TTM)

−3.77M

Op. CF (TTM)

−5.54M

Latest newsMore news →

Ping An Biomedical announced a letter of intent to acquire three tumor cell-related medical technology patents from Future Biotechnology Group for US$2 million to US$2.5 million.9d ago

Ping An Biomedical announced that its board approved a 1-for-40 reverse stock split of its Class A and Class B ordinary shares.10d ago

Similar companies

Rectitude Holdings Ltd Ordinary SharesRECT Grace Life-tech Holdings Limited02112.HK M&L Holdings Group Limited08152.HK HomesToLife LtdHTLM MBV International Limited01957.HK North Asia Strategic Holdings Limited08080.HK Find similar companies →

Latest newsMore news →

Ping An Biomedical announced a letter of intent to acquire three tumor cell-related medical technology patents from Future Biotechnology Group for US$2 million to US$2.5 million.9d ago Ping An Biomedical announced that its board approved a 1-for-40 reverse stock split of its Class A and Class B ordinary shares.10d ago